RN7SKP14

Across TCGA pan-cancer cohorts, RN7SKP14 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SKP14 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RN7SKP14 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SKP14 expression acts as an unfavorable survival marker.

UCS, THYM, and SARC are the cancer types where RN7SKP14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.128	0.538	<.001	108	view →
THYM	DFS	Tertile	II,III,IV	0.198	0.764	<.001	54	view →
SARC	DFS	Tertile	All	0.138	0.617	<.001	45	view →
ACC	OS	Tertile	III,IV	0.324	0.673	.018	21	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
STAD	OS	Tertile	All	0.409	0.737	.045	9	view →
SKCM	OS	Tertile	II,III,IV	0.193	0.731	<.001	9	view →
LIHC	OS	Tertile	All	0.450	0.712	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SKP14–UCS (DFS)

Open the UCS breakdown →